These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 24279893

  • 1. Treatment of pediatric anxiety disorders.
    Rapp A, Dodds A, Walkup JT, Rynn M.
    Ann N Y Acad Sci; 2013 Nov; 1304():52-61. PubMed ID: 24279893
    [Abstract] [Full Text] [Related]

  • 2. Behavioral psychotherapy for anxiety disorders.
    Marks I.
    Psychiatr Clin North Am; 1985 Mar; 8(1):25-35. PubMed ID: 2859579
    [Abstract] [Full Text] [Related]

  • 3. Cognitive-behavioral therapy for anxiety disorders: why and how it works.
    Basco MR, Glickman M, Weatherford P, Ryser N.
    Bull Menninger Clin; 2000 Mar; 64(3 Suppl A):A52-70. PubMed ID: 11002530
    [Abstract] [Full Text] [Related]

  • 4. Comparing outcomes for children with different anxiety disorders following cognitive behavioural therapy.
    Hudson JL, Rapee RM, Lyneham HJ, McLellan LF, Wuthrich VM, Schniering CA.
    Behav Res Ther; 2015 Sep; 72():30-7. PubMed ID: 26164621
    [Abstract] [Full Text] [Related]

  • 5. Cognitive-behavioral therapy for anxiety in youth with an autism spectrum disorder: A follow-up study.
    Selles RR, Arnold EB, Phares V, Lewin AB, Murphy TK, Storch EA.
    Autism; 2015 Jul; 19(5):613-21. PubMed ID: 24923895
    [Abstract] [Full Text] [Related]

  • 6. Relative effects of CBT and pharmacotherapy in depression versus anxiety: is medication somewhat better for depression, and CBT somewhat better for anxiety?
    Roshanaei-Moghaddam B, Pauly MC, Atkins DC, Baldwin SA, Stein MB, Roy-Byrne P.
    Depress Anxiety; 2011 Jul; 28(7):560-7. PubMed ID: 21608087
    [Abstract] [Full Text] [Related]

  • 7. Cognitive and behavioral treatments for anxiety disorders: a review of meta-analytic findings.
    Deacon BJ, Abramowitz JS.
    J Clin Psychol; 2004 Apr; 60(4):429-41. PubMed ID: 15022272
    [Abstract] [Full Text] [Related]

  • 8. A meta-analytic review of adult cognitive-behavioral treatment outcome across the anxiety disorders.
    Norton PJ, Price EC.
    J Nerv Ment Dis; 2007 Jun; 195(6):521-31. PubMed ID: 17568301
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Psychopharmacologic treatment of pediatric anxiety disorders.
    Reinblatt SP, Walkup JT.
    Child Adolesc Psychiatr Clin N Am; 2005 Oct; 14(4):877-908, x. PubMed ID: 16171707
    [Abstract] [Full Text] [Related]

  • 11. The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders.
    Schaffer A, McIntosh D, Goldstein BI, Rector NA, McIntyre RS, Beaulieu S, Swinson R, Yatham LN, Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force.
    Ann Clin Psychiatry; 2012 Feb; 24(1):6-22. PubMed ID: 22303519
    [Abstract] [Full Text] [Related]

  • 12. Childhood anxiety disorders and developmental issues in anxiety.
    Arnold P, Banerjee SP, Bhandari R, Lorch E, Ivey J, Rose M, Rosenberg DR.
    Curr Psychiatry Rep; 2003 Aug; 5(4):252-65. PubMed ID: 12857528
    [Abstract] [Full Text] [Related]

  • 13. The epidemiology of anxiety disorders in the Arab world: a review.
    Tanios CY, Abou-Saleh MT, Karam AN, Salamoun MM, Mneimneh ZN, Karam EG.
    J Anxiety Disord; 2009 May; 23(4):409-19. PubMed ID: 19091509
    [Abstract] [Full Text] [Related]

  • 14. Changes in emotion regulation following cognitive-behavioral therapy for anxious youth.
    Suveg C, Sood E, Comer JS, Kendall PC.
    J Clin Child Adolesc Psychol; 2009 May; 38(3):390-401. PubMed ID: 19437299
    [Abstract] [Full Text] [Related]

  • 15. A Meta-Analysis of D-Cycloserine in Exposure-Based Treatment: Moderators of Treatment Efficacy, Response, and Diagnostic Remission.
    McGuire JF, Wu MS, Piacentini J, McCracken JT, Storch EA.
    J Clin Psychiatry; 2017 Feb; 78(2):196-206. PubMed ID: 27314661
    [Abstract] [Full Text] [Related]

  • 16. Emotional, behavioral, and cognitive factors that differentiate obsessive-compulsive disorder and other anxiety disorders in youth.
    Jacob ML, Morelen D, Suveg C, Brown Jacobsen AM, Whiteside SP.
    Anxiety Stress Coping; 2012 Mar; 25(2):229-37. PubMed ID: 21512917
    [Abstract] [Full Text] [Related]

  • 17. Augmentation of cognitive behavioral therapy with pharmacotherapy.
    Ganasen KA, Ipser JC, Stein DJ.
    Psychiatr Clin North Am; 2010 Sep; 33(3):687-99. PubMed ID: 20599140
    [Abstract] [Full Text] [Related]

  • 18. Pharmacotherapy of anxious disorders.
    Bourin M, Lambert O.
    Hum Psychopharmacol; 2002 Dec; 17(8):383-400. PubMed ID: 12457374
    [Abstract] [Full Text] [Related]

  • 19. Cognitive behavioral therapy for 4- to 7-year-old children with anxiety disorders: a randomized clinical trial.
    Hirshfeld-Becker DR, Masek B, Henin A, Blakely LR, Pollock-Wurman RA, McQuade J, DePetrillo L, Briesch J, Ollendick TH, Rosenbaum JF, Biederman J.
    J Consult Clin Psychol; 2010 Aug; 78(4):498-510. PubMed ID: 20658807
    [Abstract] [Full Text] [Related]

  • 20. Characterizing non-OCD anxiety disorders in psychiatrically referred children and adolescents.
    Hammerness P, Harpold T, Petty C, Menard C, Zar-Kessler C, Biederman J.
    J Affect Disord; 2008 Jan; 105(1-3):213-9. PubMed ID: 17572506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.